235 related articles for article (PubMed ID: 16297773)
1. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
[TBL] [Abstract][Full Text] [Related]
2. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
4. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
Mahle WT; Vincent RN; Berg AM; Kanter KR
J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
[TBL] [Abstract][Full Text] [Related]
6. Metaanalysis of statins and survival in de novo cardiac transplantation.
Mehra MR; Raval NY
Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
[TBL] [Abstract][Full Text] [Related]
7. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
8. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
[TBL] [Abstract][Full Text] [Related]
9. The University of California at Los Angeles heart transplantation experience.
Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
11. Effect of pravastatin on outcomes after cardiac transplantation.
Kobashigawa JA; Katznelson S; Laks H; Johnson JA; Yeatman L; Wang XM; Chia D; Terasaki PI; Sabad A; Cogert GA
N Engl J Med; 1995 Sep; 333(10):621-7. PubMed ID: 7637722
[TBL] [Abstract][Full Text] [Related]
12. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
[TBL] [Abstract][Full Text] [Related]
13. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
14. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.
Mehra MR; Uber PA; Vivekananthan K; Solis S; Scott RL; Park MH; Milani RV; Lavie CJ
J Am Coll Cardiol; 2002 Nov; 40(9):1609-14. PubMed ID: 12427413
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
17. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
[TBL] [Abstract][Full Text] [Related]
18. Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.
Wenke K; Meiser B; Thiery J; Reichart B
Herz; 2005 Aug; 30(5):431-2. PubMed ID: 16132246
[TBL] [Abstract][Full Text] [Related]
19. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
[TBL] [Abstract][Full Text] [Related]
20. The University of California at Los Angeles experience in heart transplantation.
Kobashigawa JA; Laks H; Marelli D; Moriguchi JD; Hamilton MA; Fonarow G; Hage A; Kawata N
Clin Transpl; 1998; ():303-10. PubMed ID: 10503108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
